Bio-Connect

Primary

73 to 84 of 161.240 products
Sort by
Product group Antibodies
OriGene
ApplicationsImmunoFluorescence, ImmunoPrecipitation, Western Blot, ELISA
ReactivityHuman, Mouse
TargetEGFR
  • SizePrice
Detection of endogenous EGFR: Whole cell lysates of serum starved tumor cells (20.000 cells per lane) were applied to SDS-PAGE and transferred to a PVDF membrane. The immunoblot was probed with mab EGFR-13G8 (0.5 ug/ ml) for 1h at RT and developed by ECL (exp. time: 30 sec). lane 1: A431; lane 2: A549; lane 3: SKOV3; lane 4: OVCAR5; lane 5: HaCaT; lane 6: PC3; lane 7: HeLa; lane 8: HepG2
Product group Antibodies
OriGene
ApplicationsImmunoFluorescence, ImmunoPrecipitation, Western Blot, ELISA
ReactivityHuman, Mouse
TargetEGFR
  • SizePrice
ERBB2 Transactivation: Serum starved A431 cells were treated for 15 min as indicated. Whole cell lysates were separated by SDS-PAGE (ca 20.000 cells/lane). The immunoblot was probed with mab erbB2-7F8 (0.5 ug/ ml) for 1h at RT and developed by ECL (exp. time: 30 sec). Lane 1: Control Lane 2: PMA Lane 3: LPA Lane 4: Ceramide Lane 5: Bradykinin Lane 6: Bombesin
Product group Antibodies
OriGene
ApplicationsWestern Blot
ReactivityCanine, Human, Mouse
TargetERBB2
  • SizePrice
Detection of endogenous erbB2 Whole cell extracts of serum starved, EGF-treated (15 min) tumor cells (20.000 cells per lane) were applied to SDS-PAGE and transferred to a PVDF membrane. The immunoblot was probed with mab erbB2-24B5 (0.5 ug/ ml) for 1h at RT and developed by ECL (exp. time: 30 sec). Lane 1: A431 Lane 2A 549 Lane 3: SKOV3 Lane 4: OVCAR5 Lane 5: HaCaT Lane 6: PC3 Lane 7: HeLa Lane 8: HepG2
Product group Antibodies
OriGene
ApplicationsWestern Blot
ReactivityCanine, Human, Mouse
TargetERBB2
  • SizePrice
Product group Antibodies
OriGene
ApplicationsImmunoFluorescence, Western Blot
ReactivityCanine, Human, Mouse, Rat
TargetERBB2
  • SizePrice
Product group Antibodies
OriGene
ApplicationsImmunoFluorescence
ReactivityCanine, Human, Mouse, Rat
TargetERBB2
  • SizePrice
ErbB2 activation: Serum starved A549 cells were incubated with 10 ng/ml EGF for the indicated times. Whole cell lysates were prepared with lysis buffer V19 and separated by SDS-PAGE (ca 20.000 cells/lane). The immunoblot was probed with mab erbB2-19G5 (0.5 ug/ ml) for 1h at RT and developed by ECL (exp. time: 30 sec). Lane 1: Control Lane 2: 5 min EGF Lane 3: 15 min EGF Lane 4: 30 min EGF Lane 5: 1h EGF Lane 6; 2h EGF Lane 7: 4h EGF Lane 8: 8h EGF
Product group Antibodies
OriGene
ApplicationsImmunoFluorescence, Western Blot
ReactivityCanine, Human, Mouse, Rat
TargetERBB2
  • SizePrice
Product group Antibodies
OriGene
ApplicationsImmunoFluorescence, Western Blot, ELISA
ReactivityHuman
TargetERBB2
  • SizePrice
erbB2 Transactivation Serum starved A431 cells were treated for 15min as indicated. Whole cell lysates were separated by SDS-PAGE (ca 20.000 cells/lane). The immunoblot was probed with mab erbB2 - 9E10 (0.5 ug/ ml) for 1h at RT and developed by ECL (exp. time: 30 sec). lane 1: control; lane 2: TGFbeta; lane 3: Bradykinin; lane 4: Pervanadate; lane 5: Anisomycin; lane 6: PMA
Product group Antibodies
OriGene
ApplicationsImmunoFluorescence, Western Blot, ELISA
ReactivityHuman
TargetERBB2
  • SizePrice
Product group Antibodies
OriGene
ApplicationsWestern Blot
ReactivityCanine, Human, Mouse
TargetERBB2
  • SizePrice
Detection of endogenous erbB2 Whole cell extracts of serum starved tumor cells (20.000 cells per lane) were applied to SDS-PAGE and transferred to a PVDF membrane. The immunoblot was probed with mab erbB2-19D2 (0.5 ug/ ml) for 1h at RT and developed by ECL (exp. time: 30 sec). lane 1: MDA-MB 231; lane 2: MDA-MB 468; lane 3: MCF-7; lane 4: T47D; lane 5: SW480; lane 6: SW620
Product group Antibodies
OriGene
ApplicationsWestern Blot
ReactivityCanine, Human, Mouse
TargetERBB2
  • SizePrice
erbB2 activation Serum starved OVCAR-5 cells were incubated with 10 ng/ml EGF for the indicated times. Whole cell lysates were prepared with lysis buffer V19 and separated by SDS-PAGE (ca 20.000 cells/lane). The immunoblot was probed with mab erbB2 - 6G7 (0.5 ug/ ml) for 1h at RTand developed by ECL (exp. time: 30 sec). lane 1: control; lane 2: 5 min EGF; lane 3: 15 min EGF; lane 4: 30 min EGF; lane 5: 1h EGF;lane 6; 2h EGF; lane 7: 4h EGF; lane 8: 8h EGF
Product group Antibodies
OriGene
ApplicationsWestern Blot
ReactivityHuman
TargetERBB2
  • SizePrice

Didn't find what you were looking for?

Search through our product groups to find the right product

Back to overview
AntibodiesChemicalsProteins / Signaling MoleculesAssaysDNA / RNA / VectorsCell CultureGenome Editing and EngineeringMolecular BiologyLysates / ExtractsExpressionLabware / AccesoriesBody ProductsTechnique Specific ProductsArrays / SlidesDiagnosticBiologicalsMicrobiologyPromotions